Industry Sponsored Symposium - Next-Level Eosinophilic Esophagitis Care – Embracing Novel Therapies and Strategic Management Solutions

Evan S. Dellon, MD, MPH, FACG; Mirna Chehade, MD, MPH; Glenn Furuta, MD; Kristle L. Lynch, MD

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

Eosinophilic esophagitis (EoE) is a prevalent condition associated with a significant disease burden, largely due to prolonged delays in accurate diagnosis and undertreatment. When left unmanaged, EoE can severely affect a patient’s ability to eat, leading to food impaction, nutritional deficits, and increased healthcare costs. This educational program aims to equip clinicians with the knowledge and skills necessary to optimize diagnosis and management of EoE. Expert faculty will review the latest guideline recommendations and clinical data, highlighting the importance of individualized, evidence-based therapy and interprofessional collaboration for improved patient outcomes. This symposium features Curbside Consults, an interactive and dynamic case-based discussion of best practices for diagnosis and management of EoE in pediatric and adult patients.

Industry-Sponsored Satellite Symposia provide additional educational opportunities for attendees. These programs are independent of the ACG 2024 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at link www.VindicoCE.com/102824